Kallmann's syndrome: A comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 3, 2008, Pages 758-763

  Salenave, Sylvie ^a   Chanson, Philippe ^a,c,d   Bry, Hélène ^a   Pugeat, Michel ^e   Cabrol, Sylvie ^f   Carel, Jean Claude ^g   Murat, Arnaud ^h   Lecomte, Pierre ⁱ   Brailly, Sylvie ^b,c,d   Hardelin, Jean Pierre ^j   Dodé, Catherine ^k   Young, Jacques ^a,c,d  

^a BICÊTRE HOSPITAL   (France)

^b Laboratoire de Genetique Moleculaire Pharmacogenetique et Hormonologie   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSERM   (France)

^e HÔPITAL NEUROLOGIQUE   (France)

^f ARMAND TROUSSEAU HOSPITAL   (France)

^g HÔPITAL ROBERT DEBRÉ   (France)

^h NANTES UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITAL OF TOURS   (France)

^j INSTITUT PASTEUR   (France)

^k NONE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; FOLLITROPIN; GONADOTROPIN; INHIBIN B; KALLIKREIN; KALLIKREIN 1; LUTEINIZING HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTORCHISM; GENE; GENE MUTATION; HUMAN; KALLMANN SYNDROME; MALE; MALE GENITAL SYSTEM; PHENOTYPE; PRIORITY JOURNAL; PROK 2 GENE; PUBERTY DISORDERS; TESTIS FUNCTION;

EID: 40849092546     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1168     Document Type: Article

References (21)

1. Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, Wunderle V, Millasseau P, Le Paslier D, Cohen D, Caterina D, Bougueleret L, Delemarre-Van de Waal H, Lutfalla G, Weissenbach J, Petit C 1991 The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67:423-435
2. Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, Carrozzo R, Maestrini E, Pieretti M, Taillon-Miller P, Brown CJ, Willard HF, Lawrence C, Persico MG, Camerino G, Ballabio A 1991 A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353:529-536
3. Dodé C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi-Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pecheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet-Salmon B, Kottler ML, Richard O, et al 2003 Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33:463-465
4. Dodé C, Hardelin JP 2004 Kallmann syndrome: fibroblast growth factor signaling insufficiency? J Mol Med 82:725-734
5. Albuisson J, Pecheux C, Carel JC, Lacombe D, Leheup B, Lapuzina P, Bouchard P, Legius E, Matthijs G, Wasniewska M, Delpech M, Young J, Hardelin JP, Dode C 2005 Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Hum Mutat 25:98-99
6. Pitteloud N, Meysing A, Quinton R, Acierno JS Jr., Dwyer AA, Plummer L, Fliers E, Boepple P, Hayes F, Seminara S, Hughes VA, Ma J, Bouloux P, Mohammadi M, Crowley Jr WF 2006 Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol Cell Endocrinol 254-255:60-69
7. Dodé C, Fouveaut C, Mortier G, Janssens S, Bertherat J, Mahoudeau J, Kottler ML, Chabrolle C, Gancel A, François I, Devriendt K, Wolczynski S, Pugeat M, Pineiro-Garcia A, Murat A, Bouchard P, Young J, Delpech M, Hardelin JP 2007 Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis. Hum Mutat 28:97-98
8. Pitteloud N, Hayes FJ, Boepple PA, DeCruz S, Seminara SB, MacLaughlin DT, Crowley Jr WF 2002 The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:152-160
9. Quinton R, Duke VM, Robertson A, Kirk JM, Matfin G, de Zoysa PA, Azcona C, MacColl GS, Jacobs HS, Conway GS, Besser M, Stanhope RG, Bouloux PM 2001 Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol (Oxf) 55:163-174
10. Dodé C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, Lespinasse J, Lienhardt-Roussie A, Mathieu M, Moerman A, Morgan G, Murat A, Toublanc JE, Wolczynski S, Delpech M, Petit C, Young J, Hardelin JP 2006 Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2:e175
11. Hardelin JP, Levilliers J, Young J, Pholsena M, Legouis R, Kirk J, Bouloux P, Petit C, Schaison G 1993 Xp22.3 deletions in isolated familial Kallmann's syndrome. J Clin Endocrinol Metab 76:827-831
12. Eloit C, Trotier D 1994 A new clinical olfactory test to quantify olfactory deficiencies. Rhinology 32:57-61
13. Bin-Abbas B, Conte FA, Grumbach MM, Kaplan SL 1999 Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated. J Pediatr 134:579-583
14. Young J, Chanson P, Salenave S, Noel M, Brailly S, O'Flaherty M, Schaison G, Rey R 2005 Testicular anti-Mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 90:724-728
15. de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E 1997 A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 337:1597-1602
16. Thomas G, Plu G, Thalabard JC 1992 Identification of pulses in hormone time series using outlier detection methods. Stat Med 11:2133-2145
17. Oliveira LM, Seminara SB, Beranova M, Hayes FJ, Valkenburgh SB, Schipani E, Costa EM, Latronico AC, Crowley Jr WF, Vallejo M 2001 The importance of autosomal genes in Kallmann syndrome: genotype-phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab 86:1532-1538
18. Grumbach MM 2005 A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J Clin Endocrinol Metab 90:3122-3127
19. Pitteloud N, Hayes FJ, Dwyer A, Boepple PA, Lee H, Crowley Jr WF 2002 Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:4128-4136
20. Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, Dwyer A, Plummer L, Hughes V, Seminara S, Cheng YZ, Li WP, Maccoll G, Eliseenkova AV, Olsen SK, Ibrahimi OA, Hayes FJ, Boepple P, Hall JE, Bouloux P, Mohammadi M, Crowley W 2007 Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest 117:457-463
21. Gonzalez-Martinez D, Kim SH, Hu Y, Guimond S, Schofield J, Winyard P, Vannelli GB, Turnbull J, Bouloux PM 2004 Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism. J Neurosci 24:10384-10392